We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 272 results
  1. Letrozole Decreased Testosterone-Induced Cell Proliferation and Prolactin Secretion also Increased Apoptosis in MMQ and GH3 Rat Prolactinoma Cell Lines

    Aromatase enzyme plays an essential role in estrogen-induced tumorigenesis. It is expressed in the normal pituitary and more significantly in...

    Alev Selek, Zehra Seda Unal Halbutoğulları, ... Karaöz Erdal in Molecular Neurobiology
    Article 20 January 2023
  2. Curcumin Sensitizes Prolactinoma Cells to Bromocriptine by Activating the ERK/EGR1 and Inhibiting the AKT/GSK-3β Signaling Pathway In Vitro and In Vivo

    Although bromocriptine (BRC) as first-line drug is recommended for treating patients with prolactinoma, a minority of patients with prolactinoma are...

    Chao Tang, Junhao Zhu, ... Chiyuan Ma in Molecular Neurobiology
    Article 31 August 2021
  3. The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1

    Background

    Recently, a hotspot mutation in prolactinoma was observed in splicing factor 3b subunit 1 ( SF3B1 R625H ), but its functional effects and...

    **g Guo, Chuzhong Li, ... Yazhuo Zhang in Journal of Experimental & Clinical Cancer Research
    Article Open access 17 January 2022
  4. Chromophobes

    Reference work entry 2024
  5. Prolactin

    Reference work entry 2024
  6. Bromocriptine

    Reference work entry 2024
  7. Correlation of serum prolactin with sleep duration, wake-up hour, and phases of the menstrual cycle in healthy adult subjects

    Prolactin is affected by several factors: sex, age, BMI, sleep duration, menopausal status, and menstrual cycle phases. However, previous studies on...

    Darya Saeed Abdulateef in Sleep and Biological Rhythms
    Article 31 January 2023
  8. CX3CL1/CX3CR1-signalling in the CD9/S100β/SOX2-positive adult pituitary stem/progenitor cells modulates differentiation into endothelial cells

    Approximately 8% of CD9-, S100β- and SOX2-triple positive (CD9/S100β/SOX2-positive) stem/progenitor cells in the anterior lobe of the rat pituitary...

    Kotaro Horiguchi, Ken Fujiwara, ... Yukio Kato in Histochemistry and Cell Biology
    Article 09 March 2020
  9. ACT001 inhibits pituitary tumor growth by inducing autophagic cell death via MEK4/MAPK pathway

    ACT001, derived from traditional herbal medicine, is a novel compound with effective anticancer activity in clinical trials. However, little is known...

    Lin Cai, Ze-rui Wu, ... Zhi-peng Su in Acta Pharmacologica Sinica
    Article 26 January 2022
  10. The potential link between acromegaly and risk of acute ischemic stroke in patients with pituitary adenoma: a new perspective

    Acromegaly is an endocrine disorder due to the excess production of growth hormone (GH) from the anterior pituitary gland after closed epiphyseal...

    Saud A. Alnaaim, Hayder M. Al-kuraishy, ... Gaber El-Saber Batiha in Acta Neurologica Belgica
    Article Open access 16 August 2023
  11. Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine

    Nonfuctional pituitary neuroendocrine tumor (NF-PitNET) is highly heterogeneous and generally considered a common intracranial tumor. A series of...

    Siqi Wen, Chunling Li, **anquan Zhan in EPMA Journal
    Article 17 February 2022
  12. Predictive Value and Immunological Role of the HSPA5 Gene in Cervical Cancer

    Cervical cancer (CC) ranks fourth among women’s malignancies worldwide and seriously affects women’s health. HSPA5 is a heat shock protein, also...

    Yingying Bai, Yandong Miao, ... Jiang Feng in Biochemical Genetics
    Article 08 April 2024
  13. Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors

    We aimed to identify the druggable cell-intrinsic vulnerabilities and target-based drug therapies for PitNETs using the high-throughput drug...

    Yijun Cheng, Yuting Dai, ... Zhe Bao Wu in Acta Neuropathologica Communications
    Article Open access 18 April 2024
  14. Challenges in Drug Development for Neurological Disorders

    Neurological disorders are the group of pathogen, trauma, or disease induced pathologies that mainly affects our central nervous system, impairing...
    Chapter 2023
  15. Reverse Pharmacology: A Tool for Drug Discovery from Traditional Medicine

    Reverse pharmacology approach reduces the three major bottlenecks of drug discovery. In India this approach is pioneered with the traditional basis...
    Chapter 2021
  16. Hypothalamic and Pituitary Hormones

    Hypothalamus–pituitary–organ axis plays a cardinal role in the maintenance of homeostasis of human body. Hypothalamus and pituitary gland are...
    Chapter 2021
  17. Histone citrullination: a new target for tumors

    As the main protein components of chromatin, histones play central roles in gene regulation as spools of winding DNA. Histones are subject to various...

    Dongwei Zhu, Yue Zhang, Shengjun Wang in Molecular Cancer
    Article Open access 11 June 2021
  18. Granulocyte-colony stimulating factor (G-CSF): an emerging therapeutic approach for amyotrophic lateral sclerosis (ALS)

    Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by neuronal degeneration and inflammation in the nerves. G-CSF is a...

    Mahsa Vafaei Mastanabad, Aref Nooraei, ... Faria Jafarzadeh in Acta Neurologica Belgica
    Article 23 June 2022
  19. DICER1 Syndrome

    DICER1 syndrome, known previously as the pleuropulmonary blastoma—familial tumor dysplasia syndrome (OMIM #601200, #138800, #180295), was first...
    William D. Foulkes, Leanne de Kock, John R. Priest in The Hereditary Basis of Childhood Cancer
    Chapter 2021
  20. Multiple Endocrine Neoplasias and Associated Non-endocrine Conditions

    Tumors of hormone-producing tissues are frequent among patients with hereditary cancer syndromes. Lesions in multiple tumor suppressor genes and...
    Rebekah K. Jobling, Jonathan D. Wasserman in The Hereditary Basis of Childhood Cancer
    Chapter 2021
Did you find what you were looking for? Share feedback.